Clinical Approach

  • Enrico Sartori
  • Luisa Carrara
  • Brunella Pasinetti


The follow-up procedures subsequent to the primary treatment of a gynecologic malignancy can be assimilated with a screening test performed on the general population. Here the aim of monitoring is the early diagnosis and subsequent treatment of disease recurrence to improve survival of the individual and the population in question.


Endometrial Carcinoma Recurrent Cervical Cancer Asymptomatic Recurrence Risk Endometrial Carcinoma Average Time Interva 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Armstrong DK (2002) Relapsed ovarian cancer: challenges and management strategies for chronic disease. Oncologist 7:20–28CrossRefPubMedGoogle Scholar
  2. Jemal A, Siegel R, Ward E et al (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66CrossRefPubMedGoogle Scholar
  3. NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer (1995). JAMA 8:491–497Google Scholar
  4. Agboola OO, Grunfeld E, Coyle D et al (1997) Costs and benefits of routine follow-up after curative treatment for endometrial cancer. CMAJ 157:879–886PubMedGoogle Scholar
  5. Berchuck A, Anspach C, Evans AC et al (1995) Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. Gynecol Oncol 59:20–24CrossRefPubMedGoogle Scholar
  6. Kew FM, Roberts AP, Cruickshank DJ (2005) The role of routine follow-up after gynecological malignancy. Int J Gynecol Cancer 15:413–419CrossRefPubMedGoogle Scholar
  7. Podczaski E, Kaminski P, Gurski K et al (1993) Detection and patterns of treatment failure in 300 consecutive cases of ‘early’ endometrial cancer after primary surgery. Gynecol Oncol 47:323–327CrossRefGoogle Scholar
  8. Salvesen HB, Akslen LA, Iversen T et al (1997) Recurrence of endometrial carcinoma and the value of routine follow up. Br J Obstet Gynaecol 104:1302–1307PubMedGoogle Scholar
  9. Shumsky AG, Stuart GC, Brasher PM et al (1994) An evaluation of routine follow-up of patients treated for endometrial carcinoma. Gynecol Oncol 55:229–233CrossRefPubMedGoogle Scholar
  10. Tjalma WA, van Dam PA, Makar AP et al (2004) The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients. Int J Gynecol Cancer 14:931–937CrossRefPubMedGoogle Scholar
  11. Averette HE, Ngoyen HN, Donato DN et al (1993) Radical hysterectomy for invasive cervical cancer. Cancer 71:1422–1437PubMedGoogle Scholar
  12. Duyn A, Van Eijkeren M, Kenter G et al (2002) Recurrent cervical cancer: detection and prognosis. Acta Obstet Gynecol Scand 81:351–355CrossRefPubMedGoogle Scholar
  13. Sugiyama T, Yakushiji M, Noda K et al (2000) Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer. Oncology 58:31–37CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Enrico Sartori
    • 1
  • Luisa Carrara
    • 1
  • Brunella Pasinetti
    • 1
  1. 1.Department of Gynaecology and ObstetricsUniversity of Brescia A. O. Spedali CiviliBresciaItaly

Personalised recommendations